Literature DB >> 2614465

Beta-N-methylamino-L-alanine. Chronic oral administration is not neurotoxic to mice.

T L Perry1, C Bergeron, A J Biro, S Hansen.   

Abstract

Repeated dietary consumption of the neurotoxic amino acid beta-N-methylamino-L-alanine (BMAA), found in the seeds of Cycas circinalis, has been postulated as causing both amyotrophic lateral sclerosis (ALS) and the parkinsonism-dementia syndrome (PD) that were formerly very prevalent among the indigenous people of the Marianas Islands. Cynomolgus monkeys fed BMAA have been reported to develop behavioral and neuropathological changes like those found in human ALS. We gave large amounts of BMAA, totaling 15.5 g/kg of the L-isomer, by gavage to mice over 11 weeks without observing any behavioral abnormalities. When killed, these animals showed none of the neurochemical or neuropathological changes that would be expected in ALS or Parkinson's disease. Their striatal dopamine contents were normal, and there were no reductions in the contents of glutamate and aspartate in cerebral cortex like those encountered in sporadic human ALS. The results of this experiment do not support chronic ingestion of BMAA as the causative factor for Guamanian ALS or PD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614465     DOI: 10.1016/0022-510x(89)90227-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

Review 1.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

2.  Intravenous injection of l-BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson-dementia complex.

Authors:  Ke-Wei Tian; Hong Jiang; Bei-Bei Wang; Fan Zhang; Shu Han
Journal:  Toxicol Res (Camb)       Date:  2015-11-10       Impact factor: 3.524

3.  Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.

Authors:  Vanessa X Tan; Benjamin Lassus; Chai K Lim; Philippe Tixador; Josquin Courte; Alban Bessede; Gilles J Guillemin; Jean-Michel Peyrin
Journal:  Neurotox Res       Date:  2017-08-25       Impact factor: 3.911

4.  Perinatal Exposure to the Cyanotoxin β-N-Méthylamino-L-Alanine (BMAA) Results in Long-Lasting Behavioral Changes in Offspring-Potential Involvement of DNA Damage and Oxidative Stress.

Authors:  Anthony Laugeray; Asma Oummadi; Clément Jourdain; Justyne Feat; Géraldine Meyer-Dilhet; Arnaud Menuet; Karen Plé; Marion Gay; Sylvain Routier; Stéphane Mortaud; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

5.  The Evaluation of BMAA Inhalation as a Potential Exposure Route Using a rat Model.

Authors:  Laura Louise Scott; Simoné Downing; Timothy Grant Downing
Journal:  Neurotox Res       Date:  2017-05-03       Impact factor: 3.911

6.  Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms.

Authors:  Doug Lobner; Peachy Mae T Piana; Abed K Salous; Robert W Peoples
Journal:  Neurobiol Dis       Date:  2006-11-13       Impact factor: 5.996

Review 7.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

8.  Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS-PDC phenotype.

Authors:  R C Tabata; J M B Wilson; P Ly; P Zwiegers; D Kwok; J M Van Kampen; N Cashman; C A Shaw
Journal:  Neuromolecular Med       Date:  2008-01-15       Impact factor: 3.843

9.  Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus.

Authors:  Oskar Karlsson; Anna-Lena Berg; Anna-Karin Lindström; Jörg Hanrieder; Gunnel Arnerup; Erika Roman; Jonas Bergquist; Nils Gunnar Lindquist; Eva B Brittebo; Malin Andersson
Journal:  Toxicol Sci       Date:  2012-08-07       Impact factor: 4.849

10.  New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment.

Authors:  R Andrew Tasker; Amber L Adams-Marriott; Christopher A Shaw
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.